Skip to content

The application of sCD14-ST to evaluate the curative effect and prognosis of sepsis

The application of sCD14-ST to evaluate the curative effect and prognosis of sepsis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047817
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

case series:No

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Adult subjects (>=18 years old); 2. For patients with sepsis, patients with sepsis (infection or suspected infection, and SOFA score >=2 points) are selected according to the diagnostic criteria in the "2016 International Guidelines for the Diagnosis and Treatment of Severe Sepsis and Septic Shock"; 3. Subjects must give informed consent to the trial before the trial, fully understand the content and process of the trial, and voluntarily sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Research subjects with missing laboratory testing information; 2. Research subjects with missing key clinical and medical history information; 3. The investigator considers the subjects who need to terminate the trial from a medical point of view.

Design outcomes

Primary

MeasureTime frame
sCD14-ST;

Countries

china

Contacts

Public ContactRen Di

Shenzhen Second People's Hospital

59192570@qq.com+86 571 59192570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026